US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

AN2 Therapeutics, Inc.

1.22

-0.0200-1.61%

Post-market: 1.220.00000.00%16:05 EDT

Volume:201.67K

Turnover:241.18K

Market Cap:36.72M

PE:-0.71

High:1.23

Open:1.11

Low:1.11

Close:1.24

Loading ...

Overview Company News Filings

AN2 Therapeutics Inc - Ebo-301 Phase 3 Study Misses Primary Endpoint in Mac Lung Disease

THOMSON REUTERS

AN2 Therapeutics Inc - Extends Cash Runway Into 2028

THOMSON REUTERS

AN2 Therapeutics Inc - Topline Data for Melioidosis Trial Expected in 2Q25

THOMSON REUTERS

AN2 Therapeutics Reports Data From the Phase 3 Portion of Previously Terminated Ebo-301 Study and Outlines Future Milestones From Boron Chemistry Pipeline

THOMSON REUTERS

AN2 Therapeutics Reports Data from the Phase 3 Portion of Previously Terminated EBO-301 Study and Outlines Future Milestones from Boron Chemistry Pipeline

AN2 Therapeutics to Participate in Citizens JMP Life Sciences Conference

AN2 Therapeutics, Inc. (ANTX) Receives a Sell from Evercore ISI

AN2 Therapeutics, Inc.: Promising Future with Strong Financial Health and Strategic Advancements

AN2 Therapeutics Q4 2024 GAAP EPS $(0.25) Beats $(0.26) Estimate

AN2 Therapeutics: Anticipated to Fund Operations Through 2027 Under Current Strategic Plan

THOMSON REUTERS

AN2 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business and Scientific Highlights

THOMSON REUTERS

AN2 Therapeutics Q4 Net Income USD -7.522 Million

THOMSON REUTERS

Press Release: AN2 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business and Scientific Highlights

Calendar of U.S. Earnings Expected in the Week Ahead

AN2 Therapeutics to Present at Leerink Partners Global Healthcare Conference

Evercore ISI Reaffirms Their Sell Rating on AN2 Therapeutics, Inc. (ANTX)

Golden Sun Health Technology Group Leads 3 US Penny Stocks Worth Monitoring

Simply Wall St.

AN2 Therapeutics Price Target Maintained With a $5.00/Share by Citizens Capital Markets

BRIEF-AN2 Provides Strategic Update For Phase 3 Ebo-301 Trial In Treatment Refractory Mac Lung Disease

AN2 Provides Strategic Update for Phase 3 Ebo-301 Trial in Treatment Refractory Mac Lung Disease

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ANTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANTX\",,,,,undefined,":{"symbol":"ANTX","market":"US","secType":"STK","nameCN":"AN2 Therapeutics, Inc.","latestPrice":1.22,"timestamp":1746216000000,"preClose":1.24,"halted":0,"volume":201669,"hourTrading":{"tag":"盘后","latestPrice":1.22,"preClose":1.22,"latestTime":"16:05 EDT","volume":1,"amount":1.22,"timestamp":1746216308848},"delay":0,"floatShares":17669814,"shares":30098720,"eps":-1.720551,"marketStatus":"Market Closed","change":-0.02,"latestTime":"05-02 16:00:00 EDT","open":1.11,"high":1.23,"low":1.11,"amount":241178.3321,"amplitude":0.096774,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.720551,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1648180800000,"exchange":"NASDAQ","adjPreClose":1.24,"preHourTrading":{"tag":"盘前","latestPrice":1.1,"preClose":1.24,"latestTime":"08:00 EDT","volume":4723,"amount":5193.93033,"timestamp":1746187204116},"postHourTrading":{"tag":"盘后","latestPrice":1.22,"preClose":1.22,"latestTime":"16:05 EDT","volume":1,"amount":1.22,"timestamp":1746216308848},"volumeRatio":4.420510635914434},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANTX\",,,,,undefined,":{"symbol":"ANTX","floatShares":17669814,"roa":"-29.54%","roe":"-49.69%","lyrEps":-1.720551,"volumeRatio":4.420510635914434,"shares":30098720,"dividePrice":2.625,"high":1.23,"amplitude":0.096774,"preClose":1.24,"low":1.11,"week52Low":0.87,"pbRate":"0.45","week52High":3.07,"institutionHeld":0,"latestPrice":1.22,"eps":-1.720551,"divideRate":2.151639,"volume":201669,"delay":0,"ttmEps":-1.720551,"open":1.11,"prevYearClose":1.38,"prevWeekClose":1.25,"prevMonthClose":1.24,"prevQuarterClose":1.36,"fiveDayClose":1.25,"twentyDayClose":1.4,"sixtyDayClose":1.17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532988785","title":"AN2 Therapeutics Inc - Ebo-301 Phase 3 Study Misses Primary Endpoint in Mac Lung Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2532988785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532988785?lang=en_us&edition=fundamental","pubTime":"2025-05-02 04:00","pubTimestamp":1746129612,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nFWN3R93EW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2532887885","title":"AN2 Therapeutics Inc - Extends Cash Runway Into 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2532887885","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532887885?lang=en_us&edition=fundamental","pubTime":"2025-05-02 04:00","pubTimestamp":1746129612,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nFWN3R93EW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2532882099","title":"AN2 Therapeutics Inc - Topline Data for Melioidosis Trial Expected in 2Q25","url":"https://stock-news.laohu8.com/highlight/detail?id=2532882099","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532882099?lang=en_us&edition=fundamental","pubTime":"2025-05-02 04:00","pubTimestamp":1746129612,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nFWN3R93EW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2532088277","title":"AN2 Therapeutics Reports Data From the Phase 3 Portion of Previously Terminated Ebo-301 Study and Outlines Future Milestones From Boron Chemistry Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2532088277","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532088277?lang=en_us&edition=fundamental","pubTime":"2025-05-02 04:00","pubTimestamp":1746129612,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nFWN3R93EW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2532512839","title":"AN2 Therapeutics Reports Data from the Phase 3 Portion of Previously Terminated EBO-301 Study and Outlines Future Milestones from Boron Chemistry Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2532512839","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532512839?lang=en_us&edition=fundamental","pubTime":"2025-05-02 04:00","pubTimestamp":1746129600,"startTime":"0","endTime":"0","summary":"EBO-301 truncated Phase 3 study  misses primary endpoint; results unable to confirm clinical efficacy observed in Phase 2 study, patients had underlying severe, advanced MAC lung disease. Extensive enabling NTM data provides potential path forward in M. abscessus lung disease. Company focus remains centered on boron chemistry pipeline with initiation of high impact clinical programs in infectious diseases and an emerging oncology portfolio. Initiated start up activities for Phase 1 first in human study in healthy volunteers of AN2-502998, under development to treat chronic Chagas disease. Topline data for standard-of-care melioidosis observational trial expected in 2Q25; Phase 2 study planned for 2H25 with goal of reducing mortality from observed rates approaching 40%. First oncology compound from boron chemistry platform on track to advance into development in 2H25; targets best-in-class profiles with fully owned IP; novel oncology compounds target ENPP1, PI3Kα and other undisclosed t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/an2-therapeutics-reports-data-phase-200000802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","ANTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2531603576","title":"AN2 Therapeutics to Participate in Citizens JMP Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2531603576","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531603576?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:00","pubTimestamp":1746010800,"startTime":"0","endTime":"0","summary":"Eric Easom, Co-Founder, Chairman, President and CEO will participate in a fireside chat on Wednesday, May 7, 2025 at 9:00 am ET, and members of management will be available for 1X1 meetings.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/an2-therapeutics-participate-citizens-jmp-110000939.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ANTX","BK4127","LENZ","BK4007","JMP"],"gpt_icon":0},{"id":"2524130755","title":"AN2 Therapeutics, Inc. (ANTX) Receives a Sell from Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2524130755","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524130755?lang=en_us&edition=fundamental","pubTime":"2025-04-01 13:56","pubTimestamp":1743486981,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Liisa Bayko maintained a Sell rating on AN2 Therapeutics, Inc. (ANTX – Research Report) yesterday and set a price target of $2...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/an2-therapeutics-inc-antx-receives-a-sell-from-evercore-isi-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/an2-therapeutics-inc-antx-receives-a-sell-from-evercore-isi-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2522282893","title":"AN2 Therapeutics, Inc.: Promising Future with Strong Financial Health and Strategic Advancements","url":"https://stock-news.laohu8.com/highlight/detail?id=2522282893","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522282893?lang=en_us&edition=fundamental","pubTime":"2025-03-26 12:25","pubTimestamp":1742963113,"startTime":"0","endTime":"0","summary":"Analyst Roy Buchanan of JMP Securities reiterated a Buy rating on AN2 Therapeutics, Inc. (ANTX – Research Report), retaining the price target of $5...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/an2-therapeutics-inc-promising-future-with-strong-financial-health-and-strategic-advancements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/an2-therapeutics-inc-promising-future-with-strong-financial-health-and-strategic-advancements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2522874538","title":"AN2 Therapeutics Q4 2024 GAAP EPS $(0.25) Beats $(0.26) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522874538","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522874538?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:06","pubTimestamp":1742933177,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.26) by 3.85 percent. This is a 56.14 percent increase over losses of $(0.57) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44481284/an2-therapeutics-q4-2024-gaap-eps-0-25-beats-0-26-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","LENZ"],"gpt_icon":0},{"id":"2522887512","title":"AN2 Therapeutics: Anticipated to Fund Operations Through 2027 Under Current Strategic Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2522887512","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522887512?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:00","pubTimestamp":1742932801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA22Z1D1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2522887379","title":"AN2 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business and Scientific Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2522887379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522887379?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:00","pubTimestamp":1742932801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA22Z1D1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2522887372","title":"AN2 Therapeutics Q4 Net Income USD -7.522 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522887372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522887372?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:00","pubTimestamp":1742932800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nPLXEEEB5D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2522887324","title":"Press Release: AN2 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business and Scientific Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2522887324","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522887324?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:00","pubTimestamp":1742932800,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business and Scientific Highlights. Phase 3 topline data expected 2Q25 for epetraborole in patients with treatment-refractory MAC lung disease . Phase 1 first in human study of AN2-502998, under development for Chagas disease, to start mid-2025 in healthy volunteers. Topline data for melioidosis observational trial expected in 2Q25; Phase 2 epetraborole study planned for 2H25. Cash, cash equivalents, and investments of $88.6 million at December 31, 2024 anticipated to fund operations through 2027 under current strategic plan. In February 2025, the Company submitted an amended statistical analysis plan to the FDA selecting the Quality of Life -- Bronchiectasis  respiratory domain patient reported outcome  instrument as the primary efficacy endpoint for the Phase 3 part of the EBO-301 trial. The Company believes that this approach aligns with current FDA Guidance for Industry on NTM drug development r","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","PRO","LENZ","BK4007","BK4139","ANTX"],"gpt_icon":0},{"id":"2521714099","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2521714099","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521714099?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:00","pubTimestamp":1742810400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Comp de San Bas                                  4Q       .36       AMC. ·Oklo Inc. Class A                               4Q      (.07)      AMC. ·Core & Main Inc.                                 4Q       .36       BMO. ·McCormick & Co                                 1Q       .64   6:30 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHWY","IKT","SDST","BCAB","WOOF","IOBT","KOD","NUTX","CTAS","DLTR","MKC","OBIO","PAYX","TEN","PDSB","SKYX","ANTX","UNCY","FBIO","IVA","RLMD","CRMD","WBA","SLRN","BEEM","AFMD","RVPH","CLSD","EDAP","MLKN","KBH","SCS","WGO","XFOR","LPTX","MREO","CNXC","MDAI","GOVX","CDLR","THRD","PAYS","ACRV","SURG","ALUR","ZURA","DERM","ABL","CALC","GRDN"],"gpt_icon":0},{"id":"2516666305","title":"AN2 Therapeutics to Present at Leerink Partners Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2516666305","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516666305?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:00","pubTimestamp":1741035600,"startTime":"0","endTime":"0","summary":"Eric Easom, Co-Founder, Chairman, President and CEO, will provide a corporate overview on Wednesday, March 12, 2025 at 2:20 pm ET, and members of management will be available for 1X1 meetings.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/an2-therapeutics-present-leerink-partners-210000228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ANTX","HCSG","BK4139","LENZ","BK4007","BK4137"],"gpt_icon":0},{"id":"2514000870","title":"Evercore ISI Reaffirms Their Sell Rating on AN2 Therapeutics, Inc. (ANTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514000870","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514000870?lang=en_us&edition=fundamental","pubTime":"2025-02-26 13:45","pubTimestamp":1740548736,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Liisa Bayko maintained a Sell rating on AN2 Therapeutics, Inc. (ANTX – Research Report) yesterday and set a price target of $2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evercore-isi-reaffirms-their-sell-rating-on-an2-therapeutics-inc-antx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evercore-isi-reaffirms-their-sell-rating-on-an2-therapeutics-inc-antx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANTX"],"gpt_icon":0},{"id":"2514904689","title":"Golden Sun Health Technology Group Leads 3 US Penny Stocks Worth Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2514904689","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514904689?lang=en_us&edition=fundamental","pubTime":"2025-02-26 04:11","pubTimestamp":1740514312,"startTime":"0","endTime":"0","summary":"As the S&P 500 and Nasdaq Composite continue to experience declines, investor sentiment is being tested by economic uncertainties and fluctuating market conditions. Despite these challenges, penny stocks remain a notable segment for investors seeking opportunities in smaller or newer companies. While the term \"penny stocks\" may seem outdated, it still encapsulates firms that have the potential for growth when backed by strong financials. In this context, certain penny stocks are emerging as intriguing options for those interested in exploring under-the-radar investments with promising prospects.Click here to see the full list of 728 stocks from our US Penny Stocks screener.Overview: Golden Sun Health Technology Group Limited operates in China, offering education services related to medical health, e-commerce live broadcasting, and cultural and tourism services, with a market cap of $5.25 million.Get an in-depth perspective on Golden Sun Health Technology Group's performance by reading ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/golden-sun-health-technology-group-201152293.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","PHX","PVL","ANTX","BK4021","NRT","BK4213","BABB","BK4563","BK4209","SB","BK4204","NTWK","GSUN"],"gpt_icon":0},{"id":"2514016442","title":"AN2 Therapeutics Price Target Maintained With a $5.00/Share by Citizens Capital Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016442","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514016442?lang=en_us&edition=fundamental","pubTime":"2025-02-25 23:42","pubTimestamp":1740498120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 25, 2025 10:42 ET (15:42 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","LENZ"],"gpt_icon":0},{"id":"2513729385","title":"BRIEF-AN2 Provides Strategic Update For Phase 3 Ebo-301 Trial In Treatment Refractory Mac Lung Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2513729385","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513729385?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:24","pubTimestamp":1740403466,"startTime":"0","endTime":"0","summary":"BRIEF-AN2 Provides Strategic Update For Phase 3 Ebo-301 Trial In Treatment Refractory Mac Lung DiseaseFeb 24 (Reuters) - AN2 Therapeutics Inc ANTX.O:AN2 PROVIDES STRATEGIC UPDATE FOR PHASE 3 EBO-301 T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUA4LXLQY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2513740698","title":"AN2 Provides Strategic Update for Phase 3 Ebo-301 Trial in Treatment Refractory Mac Lung Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2513740698","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513740698?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUA4LXLQY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANTX","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":34,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANTX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.2,"hold":0.6,"sell":0.2,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6,"analysts":5,"updateTime":1736481600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANTX","date":"2025-05-02","current":-0.727235,"percent":0.8,"low":-16.371108,"twenty":-8.4839,"median":-4.504122,"eighty":-0.727235,"high":-0.452319,"avg":-4.810889,"sd":3.943034,"marketCap":37322412},"quantilePoints":[{"date":"2022-03-25","current":-13.396124,"twenty":-13.256944,"median":-13.048173,"eighty":-12.797512,"marketCap":288592704},{"date":"2022-04-01","current":-13.735377,"twenty":-13.389165,"median":-13.082968,"eighty":-13.048173,"marketCap":295901220},{"date":"2022-04-08","current":-13.126462,"twenty":-13.389165,"median":-13.126462,"eighty":-13.048173,"marketCap":282783370},{"date":"2022-04-14","current":-12.195692,"twenty":-13.35611,"median":-13.056872,"eighty":-12.282634,"marketCap":262731799},{"date":"2022-04-22","current":-12.674125,"twenty":-13.265642,"median":-13.043824,"eighty":-12.188734,"marketCap":273038682},{"date":"2022-04-29","current":-13.596196,"twenty":-13.35611,"median":-13.048173,"eighty":-12.282634,"marketCap":292902855},{"date":"2022-05-06","current":-16.371108,"twenty":-13.735377,"median":-13.082968,"eighty":-12.639148,"marketCap":352682772},{"date":"2022-05-13","current":-12.634954,"twenty":-13.707541,"median":-13.048173,"eighty":-12.337661,"marketCap":343038993},{"date":"2022-05-20","current":-7.432326,"twenty":-13.556182,"median":-13.043824,"eighty":-12.180035,"marketCap":201787643},{"date":"2022-05-27","current":-10.426695,"twenty":-13.392645,"median":-13.013378,"eighty":-11.61546,"marketCap":283084780},{"date":"2022-06-03","current":-11.20566,"twenty":-13.378727,"median":-12.769812,"eighty":-10.726847,"marketCap":304233677},{"date":"2022-06-10","current":-6.882048,"twenty":-13.265642,"median":-12.632679,"eighty":-9.433336,"marketCap":186847596},{"date":"2022-06-17","current":-6.081643,"twenty":-13.265642,"median":-12.334802,"eighty":-8.368513,"marketCap":165116619},{"date":"2022-06-24","current":-6.253159,"twenty":-13.196052,"median":-12.186994,"eighty":-7.795366,"marketCap":169773257},{"date":"2022-07-01","current":-5.831517,"twenty":-13.172482,"median":-12.113054,"eighty":-7.105018,"marketCap":158325689},{"date":"2022-07-08","current":-6.424674,"twenty":-13.15991,"median":-11.715613,"eighty":-6.370361,"marketCap":174429895},{"date":"2022-07-15","current":-6.360356,"twenty":-13.1369,"median":-11.019852,"eighty":-6.253159,"marketCap":172683656},{"date":"2022-07-22","current":-5.881542,"twenty":-13.116023,"median":-10.573198,"eighty":-6.184553,"marketCap":159683875},{"date":"2022-07-29","current":-6.117376,"twenty":-13.077749,"median":-9.433336,"eighty":-5.990169,"marketCap":166086752},{"date":"2022-08-05","current":-7.28225,"twenty":-13.051653,"median":-8.550748,"eighty":-5.92728,"marketCap":197713085},{"date":"2022-08-12","current":-11.654946,"twenty":-13.048173,"median":-8.368513,"eighty":-5.964441,"marketCap":376023512},{"date":"2022-08-19","current":-11.973683,"twenty":-13.048173,"median":-8.836607,"eighty":-5.990169,"marketCap":386306920},{"date":"2022-08-26","current":-9.447843,"twenty":-13.042954,"median":-9.447843,"eighty":-6.034477,"marketCap":304815757},{"date":"2022-09-02","current":-7.685769,"twenty":-13.039474,"median":-9.296256,"eighty":-6.073067,"marketCap":247965969},{"date":"2022-09-09","current":-5.683139,"twenty":-13.031725,"median":-8.930422,"eighty":-5.955866,"marketCap":183355118},{"date":"2022-09-16","current":-5.310277,"twenty":-13.017412,"median":-8.532882,"eighty":-5.851527,"marketCap":171325470},{"date":"2022-09-23","current":-6.735572,"twenty":-12.958334,"median":-8.22201,"eighty":-5.820083,"marketCap":217309769},{"date":"2022-09-30","current":-10.452165,"twenty":-12.87166,"median":-8.485618,"eighty":-5.827229,"marketCap":337218196},{"date":"2022-10-07","current":-10.758874,"twenty":-12.827224,"median":-8.662429,"eighty":-5.851527,"marketCap":347113551},{"date":"2022-10-14","current":-10.75286,"twenty":-12.732811,"median":-9.159176,"eighty":-5.887259,"marketCap":346919525},{"date":"2022-10-21","current":-9.868816,"twenty":-12.676035,"median":-9.377444,"eighty":-5.901552,"marketCap":318397617},{"date":"2022-10-28","current":-9.056939,"twenty":-12.658457,"median":-9.321551,"eighty":-5.921562,"marketCap":292204029},{"date":"2022-11-04","current":-9.604204,"twenty":-12.633134,"median":-9.294488,"eighty":-5.955866,"marketCap":309860448},{"date":"2022-11-11","current":-7.870305,"twenty":-12.51788,"median":-9.213301,"eighty":-5.98731,"marketCap":288517524},{"date":"2022-11-18","current":-6.891148,"twenty":-12.343378,"median":-9.131888,"eighty":-6.021613,"marketCap":252622607},{"date":"2022-11-25","current":-5.8326,"twenty":-12.30698,"median":-9.032884,"eighty":-5.94729,"marketCap":213817291},{"date":"2022-12-02","current":-5.102202,"twenty":-12.193952,"median":-8.756244,"eighty":-5.842388,"marketCap":187041623},{"date":"2022-12-09","current":-4.726417,"twenty":-12.185254,"median":-8.550748,"eighty":-5.80579,"marketCap":173265735},{"date":"2022-12-16","current":-5.181593,"twenty":-12.178295,"median":-8.404872,"eighty":-5.725749,"marketCap":189952021},{"date":"2022-12-23","current":-5.043982,"twenty":-12.152199,"median":-8.130215,"eighty":-5.685509,"marketCap":184907330},{"date":"2022-12-30","current":-5.043982,"twenty":-12.047813,"median":-8.043349,"eighty":-5.617123,"marketCap":184907330},{"date":"2023-01-06","current":-5.361546,"twenty":-11.988509,"median":-7.887149,"eighty":-5.544229,"marketCap":196548925},{"date":"2023-01-13","current":-5.642062,"twenty":-11.900765,"median":-7.790914,"eighty":-5.514548,"marketCap":206832334},{"date":"2023-01-20","current":-5.292741,"twenty":-11.857841,"median":-7.780329,"eighty":-5.486455,"marketCap":194026580},{"date":"2023-01-27","current":-6.652975,"twenty":-11.83416,"median":-7.52668,"eighty":-5.481434,"marketCap":243891411},{"date":"2023-02-03","current":-8.256675,"twenty":-11.724707,"median":-7.50379,"eighty":-5.486455,"marketCap":302681464},{"date":"2023-02-10","current":-7.621547,"twenty":-11.591193,"median":-7.550498,"eighty":-5.497097,"marketCap":279398275},{"date":"2023-02-17","current":-7.224591,"twenty":-11.42481,"median":-7.520984,"eighty":-5.503782,"marketCap":264846281},{"date":"2023-02-24","current":-6.409509,"twenty":-11.289301,"median":-7.50379,"eighty":-5.509499,"marketCap":234966188},{"date":"2023-03-03","current":-5.456816,"twenty":-11.208214,"median":-7.426374,"eighty":-5.509499,"marketCap":200041403},{"date":"2023-03-10","current":-4.578221,"twenty":-11.173685,"median":-7.303982,"eighty":-5.480511,"marketCap":167832991},{"date":"2023-03-17","current":-4.684075,"twenty":-11.125722,"median":-7.239128,"eighty":-5.439451,"marketCap":171713523},{"date":"2023-03-24","current":-5.493865,"twenty":-11.125722,"median":-7.16076,"eighty":-5.330785,"marketCap":201399590},{"date":"2023-03-31","current":-4.675853,"twenty":-11.084828,"median":-7.064148,"eighty":-5.270511,"marketCap":191504234},{"date":"2023-04-06","current":-4.230534,"twenty":-11.023486,"median":-6.924927,"eighty":-5.260984,"marketCap":173265735},{"date":"2023-04-14","current":-4.216321,"twenty":-11.019852,"median":-6.821303,"eighty":-5.202027,"marketCap":172683656},{"date":"2023-04-21","current":-4.007874,"twenty":-10.916914,"median":-6.735572,"eighty":-5.163355,"marketCap":164146486},{"date":"2023-04-28","current":-3.789856,"twenty":-10.785335,"median":-6.531871,"eighty":-5.110953,"marketCap":155217351},{"date":"2023-05-04","current":-2.741598,"twenty":-10.756468,"median":-6.516471,"eighty":-5.079973,"marketCap":112284892},{"date":"2023-05-12","current":-2.021591,"twenty":-10.742455,"median":-6.4889,"eighty":-5.044655,"marketCap":98297847},{"date":"2023-05-19","current":-3.128272,"twenty":-10.723989,"median":-6.417091,"eighty":-5.017615,"marketCap":152109119},{"date":"2023-05-26","current":-2.225348,"twenty":-10.658392,"median":-6.345996,"eighty":-4.977293,"marketCap":108205337},{"date":"2023-06-02","current":-2.385158,"twenty":-10.566429,"median":-6.281745,"eighty":-4.901078,"marketCap":115975918},{"date":"2023-06-09","current":-2.560948,"twenty":-10.530346,"median":-6.253159,"eighty":-4.858736,"marketCap":124523557},{"date":"2023-06-16","current":-2.916525,"twenty":-10.482234,"median":-6.179275,"eighty":-4.763467,"marketCap":141813099},{"date":"2023-06-23","current":-2.816644,"twenty":-10.458179,"median":-6.099509,"eighty":-4.692657,"marketCap":136956486},{"date":"2023-06-30","current":-3.356001,"twenty":-10.436883,"median":-6.046964,"eighty":-4.666378,"marketCap":163182196},{"date":"2023-07-07","current":-3.515811,"twenty":-10.412827,"median":-5.988739,"eighty":-4.546389,"marketCap":170952777},{"date":"2023-07-14","current":-3.096311,"twenty":-10.358348,"median":-5.938714,"eighty":-4.379111,"marketCap":150555003},{"date":"2023-07-21","current":-3.096311,"twenty":-10.284978,"median":-5.895835,"eighty":-4.25703,"marketCap":150555003},{"date":"2023-07-28","current":-3.268106,"twenty":-10.193567,"median":-5.832059,"eighty":-4.205213,"marketCap":158908377},{"date":"2023-08-04","current":-3.216168,"twenty":-10.158686,"median":-5.817224,"eighty":-4.029666,"marketCap":156382938},{"date":"2023-08-11","current":-3.356001,"twenty":-10.014353,"median":-5.791146,"eighty":-3.845856,"marketCap":163182196},{"date":"2023-08-18","current":-5.688753,"twenty":-9.981877,"median":-5.731467,"eighty":-3.79935,"marketCap":308944792},{"date":"2023-08-25","current":-8.204932,"twenty":-9.916927,"median":-5.791146,"eighty":-3.845856,"marketCap":445593450},{"date":"2023-09-01","current":-8.226812,"twenty":-9.859194,"median":-5.817224,"eighty":-3.898925,"marketCap":446781699},{"date":"2023-09-08","current":-8.50578,"twenty":-9.820705,"median":-5.831517,"eighty":-3.974712,"marketCap":461931876},{"date":"2023-09-15","current":-7.915024,"twenty":-9.604204,"median":-5.888688,"eighty":-4.007874,"marketCap":429849148},{"date":"2023-09-22","current":-7.554007,"twenty":-9.586163,"median":-5.938714,"eighty":-4.029192,"marketCap":410243036},{"date":"2023-09-29","current":-8.730048,"twenty":-9.561973,"median":-5.988739,"eighty":-4.031561,"marketCap":474111430},{"date":"2023-10-06","current":-8.292451,"twenty":-9.447843,"median":-6.060204,"eighty":-4.121573,"marketCap":450346446},{"date":"2023-10-13","current":-8.068183,"twenty":-9.447843,"median":-6.108187,"eighty":-4.154735,"marketCap":438166892},{"date":"2023-10-20","current":-7.958784,"twenty":-9.433336,"median":-6.21897,"eighty":-4.202436,"marketCap":432225646},{"date":"2023-10-27","current":-8.062713,"twenty":-9.388622,"median":-6.246012,"eighty":-4.20799,"marketCap":437869830},{"date":"2023-11-03","current":-8.204932,"twenty":-9.299901,"median":-6.263879,"eighty":-4.222006,"marketCap":445593450},{"date":"2023-11-10","current":-8.42373,"twenty":-9.245776,"median":-6.345996,"eighty":-4.238114,"marketCap":457475942},{"date":"2023-11-17","current":-8.188416,"twenty":-9.191651,"median":-6.417091,"eighty":-4.251835,"marketCap":488651941},{"date":"2023-11-24","current":-8.592106,"twenty":-9.159176,"median":-6.462436,"eighty":-4.25703,"marketCap":512742511},{"date":"2023-12-01","current":-8.756572,"twenty":-9.148261,"median":-6.515364,"eighty":-4.263696,"marketCap":522557188},{"date":"2023-12-08","current":-9.369582,"twenty":-9.256601,"median":-6.592423,"eighty":-4.286376,"marketCap":559139166},{"date":"2023-12-15","current":-10.181945,"twenty":-9.420585,"median":-6.735572,"eighty":-4.378104,"marketCap":607617721},{"date":"2023-12-22","current":-10.216831,"twenty":-9.539147,"median":-6.886598,"eighty":-4.40653,"marketCap":609699622},{"date":"2023-12-29","current":-10.416184,"twenty":-9.612102,"median":-6.924927,"eighty":-4.479724,"marketCap":621596200},{"date":"2024-01-05","current":-9.638708,"twenty":-9.641698,"median":-7.064148,"eighty":-4.516825,"marketCap":575199546},{"date":"2024-01-12","current":-10.431136,"twenty":-9.849572,"median":-7.123402,"eighty":-4.535879,"marketCap":622488443},{"date":"2024-01-19","current":-9.892883,"twenty":-9.923734,"median":-7.161078,"eighty":-4.541134,"marketCap":590367683},{"date":"2024-01-26","current":-9.912818,"twenty":-9.910825,"median":-7.239128,"eighty":-4.565367,"marketCap":591557341},{"date":"2024-02-02","current":-9.937737,"twenty":-9.925728,"median":-7.28225,"eighty":-4.59301,"marketCap":593044413},{"date":"2024-02-09","current":-9.96764,"twenty":-9.966643,"median":-7.362202,"eighty":-4.656903,"marketCap":594828900},{"date":"2024-02-16","current":-1.918771,"twenty":-9.966643,"median":-7.303982,"eighty":-4.541134,"marketCap":114504563},{"date":"2024-02-23","current":-1.649644,"twenty":-9.962656,"median":-7.2641,"eighty":-4.382132,"marketCap":98444182},{"date":"2024-03-01","current":-1.485178,"twenty":-9.942721,"median":-7.216995,"eighty":-4.255363,"marketCap":88629506},{"date":"2024-03-08","current":-1.465243,"twenty":-9.937737,"median":-7.16076,"eighty":-4.202436,"marketCap":87439848},{"date":"2024-03-15","current":-1.515081,"twenty":-9.928955,"median":-7.0934,"eighty":-4.029192,"marketCap":90413992},{"date":"2024-03-22","current":-1.649644,"twenty":-9.912818,"median":-6.924927,"eighty":-3.837326,"marketCap":98444182},{"date":"2024-03-28","current":-1.60479,"twenty":-9.904844,"median":-6.882048,"eighty":-3.54138,"marketCap":95767452},{"date":"2024-04-05","current":-1.493229,"twenty":-9.894877,"median":-6.735572,"eighty":-3.40709,"marketCap":96659696},{"date":"2024-04-12","current":-1.379706,"twenty":-9.873629,"median":-6.531871,"eighty":-3.34002,"marketCap":89311125},{"date":"2024-04-19","current":-1.094567,"twenty":-9.830327,"median":-6.512717,"eighty":-3.300068,"marketCap":70853492},{"date":"2024-04-26","current":-1.048577,"twenty":-9.7389,"median":-6.435973,"eighty":-3.275297,"marketCap":67876455},{"date":"2024-05-03","current":-1.170453,"twenty":-9.714462,"median":-6.384932,"eighty":-3.243335,"marketCap":75765761},{"date":"2024-05-10","current":-1.138196,"twenty":-9.689543,"median":-6.288891,"eighty":-3.200986,"marketCap":73677728},{"date":"2024-05-17","current":-1.025534,"twenty":-9.683563,"median":-6.253159,"eighty":-3.153842,"marketCap":67711920},{"date":"2024-05-24","current":-0.908072,"twenty":-9.651666,"median":-6.21897,"eighty":-3.096311,"marketCap":59956370},{"date":"2024-05-31","current":-0.921625,"twenty":-9.640702,"median":-6.117376,"eighty":-3.032764,"marketCap":60851241},{"date":"2024-06-07","current":-0.944214,"twenty":-9.626747,"median":-6.070923,"eighty":-2.970061,"marketCap":62342693},{"date":"2024-06-14","current":-0.899037,"twenty":-9.612945,"median":-6.014805,"eighty":-2.882965,"marketCap":59359789},{"date":"2024-06-21","current":-0.935179,"twenty":-9.600596,"median":-5.975902,"eighty":-2.800663,"marketCap":61746112},{"date":"2024-06-28","current":-1.007463,"twenty":-9.593379,"median":-5.954462,"eighty":-2.72642,"marketCap":66518759},{"date":"2024-07-05","current":-1.224316,"twenty":-9.576487,"median":-5.902982,"eighty":-2.560948,"marketCap":80836698},{"date":"2024-07-12","current":-1.147514,"twenty":-9.548809,"median":-5.8326,"eighty":-2.429778,"marketCap":75765761},{"date":"2024-07-15","current":-1.165585,"twenty":-9.542228,"median":-5.832059,"eighty":-2.4146,"marketCap":76958923},{"date":"2024-08-02","current":-1.152032,"twenty":-9.535646,"median":-5.831517,"eighty":-2.400893,"marketCap":76064052},{"date":"2024-08-09","current":-1.192692,"twenty":-9.469258,"median":-5.810078,"eighty":-2.273291,"marketCap":78748665},{"date":"2024-08-16","current":-0.47057,"twenty":-9.449136,"median":-5.779362,"eighty":-2.170214,"marketCap":30425620},{"date":"2024-08-23","current":-0.51232,"twenty":-9.447843,"median":-5.727894,"eighty":-2.006011,"marketCap":33125098},{"date":"2024-08-30","current":-0.521551,"twenty":-9.44504,"median":-5.717174,"eighty":-1.838033,"marketCap":33721947},{"date":"2024-09-06","current":-0.475396,"twenty":-9.437737,"median":-5.688753,"eighty":-1.659612,"marketCap":30737703},{"date":"2024-09-13","current":-0.480012,"twenty":-9.395084,"median":-5.681125,"eighty":-1.602796,"marketCap":31036128},{"date":"2024-09-20","current":-0.498474,"twenty":-9.366592,"median":-5.652855,"eighty":-1.557942,"marketCap":32229825},{"date":"2024-09-27","current":-0.486935,"twenty":-9.361608,"median":-5.599013,"eighty":-1.524052,"marketCap":31483764},{"date":"2024-10-04","current":-0.480012,"twenty":-9.336776,"median":-5.546792,"eighty":-1.494379,"marketCap":31036128},{"date":"2024-10-11","current":-0.480012,"twenty":-9.293554,"median":-5.527793,"eighty":-1.485178,"marketCap":31036128},{"date":"2024-10-18","current":-0.475396,"twenty":-9.271899,"median":-5.50278,"eighty":-1.463249,"marketCap":30737703},{"date":"2024-10-25","current":-0.493858,"twenty":-9.268418,"median":-5.485925,"eighty":-1.404343,"marketCap":31931401},{"date":"2024-10-31","current":-0.503089,"twenty":-9.245776,"median":-5.467741,"eighty":-1.384784,"marketCap":32528249},{"date":"2024-11-08","current":-0.507705,"twenty":-9.191651,"median":-5.440937,"eighty":-1.238642,"marketCap":32826674},{"date":"2024-11-15","current":-0.491662,"twenty":-9.159176,"median":-5.335911,"eighty":-1.189981,"marketCap":29842431},{"date":"2024-11-22","current":-0.604745,"twenty":-9.137345,"median":-5.292741,"eighty":-1.17212,"marketCap":36706190},{"date":"2024-11-29","current":-0.822079,"twenty":-9.095067,"median":-5.266277,"eighty":-1.154743,"marketCap":49897746},{"date":"2024-12-06","current":-0.713781,"twenty":-9.047317,"median":-5.253045,"eighty":-1.141948,"marketCap":43324390},{"date":"2024-12-13","current":-0.728549,"twenty":-9.004017,"median":-5.218642,"eighty":-1.13436,"marketCap":44220757},{"date":"2024-12-20","current":-0.625174,"twenty":-8.946955,"median":-5.18424,"eighty":-1.117586,"marketCap":37946190},{"date":"2024-12-27","current":-0.679323,"twenty":-8.795687,"median":-5.159815,"eighty":-1.10594,"marketCap":41232868},{"date":"2025-01-03","current":-0.684246,"twenty":-8.764395,"median":-5.131312,"eighty":-1.091686,"marketCap":41531657},{"date":"2025-01-10","current":-0.639942,"twenty":-8.756375,"median":-5.109656,"eighty":-1.077369,"marketCap":38842557},{"date":"2025-01-17","current":-0.625174,"twenty":-8.753654,"median":-5.065153,"eighty":-1.025534,"marketCap":37946190},{"date":"2025-01-24","current":-0.615329,"twenty":-8.743176,"median":-5.054567,"eighty":-1.007463,"marketCap":37348612},{"date":"2025-01-31","current":-0.575948,"twenty":-8.706848,"median":-5.044823,"eighty":-0.965899,"marketCap":34958301},{"date":"2025-02-07","current":-0.541489,"twenty":-8.666805,"median":-5.038689,"eighty":-0.946021,"marketCap":32866779},{"date":"2025-02-14","current":-0.526721,"twenty":-8.652374,"median":-5.00164,"eighty":-0.932468,"marketCap":31970412},{"date":"2025-02-21","current":-0.556257,"twenty":-8.638152,"median":-4.986004,"eighty":-0.918011,"marketCap":33763145},{"date":"2025-02-28","current":-0.546412,"twenty":-8.61494,"median":-4.906371,"eighty":-0.89994,"marketCap":33165567},{"date":"2025-03-07","current":-0.635019,"twenty":-8.592106,"median":-4.890493,"eighty":-0.87193,"marketCap":38543768},{"date":"2025-03-14","current":-0.694091,"twenty":-8.587408,"median":-4.858736,"eighty":-0.767931,"marketCap":42129234},{"date":"2025-03-21","current":-0.718704,"twenty":-8.568081,"median":-4.787284,"eighty":-0.729534,"marketCap":43623179},{"date":"2025-03-28","current":-0.838362,"twenty":-8.559336,"median":-4.763467,"eighty":-0.729534,"marketCap":43025601},{"date":"2025-04-04","current":-0.821071,"twenty":-8.531837,"median":-4.710422,"eighty":-0.734457,"marketCap":42138208},{"date":"2025-04-11","current":-0.70964,"twenty":-8.523283,"median":-4.675853,"eighty":-0.729459,"marketCap":36419451},{"date":"2025-04-17","current":-0.750694,"twenty":-8.50578,"median":-4.652166,"eighty":-0.7331,"marketCap":38526361},{"date":"2025-04-25","current":-0.756559,"twenty":-8.485618,"median":-4.549017,"eighty":-0.7331,"marketCap":38827348},{"date":"2025-05-02","current":-0.727235,"twenty":-8.4839,"median":-4.504122,"eighty":-0.727235,"marketCap":37322412}],"updateTime":1746275511722}}}